ARROWHEAD PHARMACEUTICALS IN (ARWR) Stock Balance Sheet
NASDAQ:ARWR • US04280A1007
Current stock price
56.33 USD
-0.63 (-1.11%)
At close:
57.1826 USD
+0.85 (+1.51%)
After Hours:
| MRQ (2025-12-31) | 2025 (2025-9-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 199.74M | 224.65M | 99.19M | 103.00M | 108.00M | |||
| Marketable Securities | 714.97M | 692.82M | 578.28M | 292.70M | 268.40M | |||
| Receivables | 218.87M | 6.82M | N/A | 0.00 | 1.40M | |||
| Other Current Assets | 40.81M | 26.35M | 18.01M | 23.80M | 27.50M | |||
| Total Current Assets | 1.17B | 950.64M | 695.47M | 419.50M | 405.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 421.94M | 426.41M | 431.29M | 335.60M | 168.60M | |||
| Investments And Advances | N/A | N/A | N/A | 0.00 | 105.90M | |||
| Intangibles | 6.44M | 6.86M | 8.56M | 10.30M | 12.00M | |||
| Other Non-Current Assets | 1.41M | 1.39M | 4.48M | 200.00K | 200.00K | |||
| Total Non-Current Assets | 429.79M | 434.66M | 444.33M | 346.10M | 286.60M | |||
| TOTAL ASSETS | 1.60B | 1.39B | 1.14B | 765.60M | 691.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 40.00M | 40.00M | N/A | N/A | N/A | |||
| Accrued Expenses | 100.47M | 103.80M | 91.35M | 68.30M | 61.90M | |||
| Accounts Payable | 32.94M | 17.67M | 11.39M | 35.90M | 2.90M | |||
| Other Current Liabilities | 174.02M | 34.01M | 432.00K | 1.30M | 74.10M | |||
| Total Current Liabilities | 347.43M | 195.49M | 103.17M | 105.50M | 138.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 538.11M | 582.28M | 734.54M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 155.95M | 104.11M | 111.03M | 372.90M | 134.80M | |||
| Total Non-Current Liabilities | 688.33M | 723.76M | 851.19M | 388.70M | 154.50M | |||
| TOTAL LIABILITIES | 1.04B | 919.24M | 954.36M | 494.20M | 293.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.60B | -1.63B | -1.63B | -1.03B | -820.80M | |||
| Additional Paid In Capital | 2.21B | 2.14B | 1.81B | 1.30B | 1.22B | |||
| Minority Interest | -5.72M | 37.36M | 5.62M | 15.80M | 19.80M | |||
| Common Shares | 233.00K | 231.00K | 217.00K | 200.00K | 200.00K | |||
| Treasury Stock | -53.19M | -53.19M | N/A | N/A | N/A | |||
| Other Shareholders' Equity | 6.70M | 6.44M | 4.75M | -3.20M | -100.00K | |||
| Shares Outstanding | 137.39M | 135.70M | 124.38M | 107.30M | 106.00M | |||
| Tangible Book Value per Share | 4.09 | 3.38 | 1.42 | 2.43 | 3.65 | |||
| Total Shareholders' Equity | 568.42M | 466.05M | 185.44M | 271.30M | 398.50M | |||
| TOTAL LIABILITIES AND EQUITY | 1.60B | 1.39B | 1.14B | 765.60M | 691.90M | |||
| Statistics | ||||||||
| Debt/Equity | 0.95 | 1.25 | 3.96 | N/A | N/A | |||
| Current Ratio | 3.38 | 4.86 | 6.74 | 3.98 | 2.92 | |||
| Return On Assets (ROA) | 12.61% | -0.12% | -52.60% | -26.82% | -25.45% | |||
| Return On Equity (ROE) | 35.58% | -0.35% | -323.27% | -75.67% | -44.19% | |||
| Return On Invested Capital (ROIC) | 13.98% | 4.83% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 51.35% | 21.10% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 52.33% | 21.65% | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.42